Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an Evrysdi® ...
The European Medicines Agency said the portal will enable consultations with medical device expert panels that can promote faster access to new technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback